Related by context. Frequent words. (Click for all words.) 76 visit www.PAREXEL.com 74 please visit http:/www.supergen.com 72 Inc Therapeutic Competitors 71 www.holliseden.com 70 www.vivus.com 70 www.utekcorp.com 70 www.syntapharma.com 70 please visit TomoTherapy.com 70 programs visit http:/www.nih.gov 69 Initiates Phase II 69 www.combinatorx.com 69 Therapeutic Competitors 69 www.spectrumpharm.com 68 Announces FDA Clearance 68 website www.octoplus.nl 68 http:/www.nabi.com 68 please visit www.inhibitex.com 68 Receives Orphan Drug Designation 68 www.lannett.com 68 www.caliperLS.com 68 visit www.siemens.com plm 68 Presents Positive 67 Earnings Postmortem 67 Welcomes Analyst Initiation 67 Files Shelf Registration Statement 67 programs visit www.nih.gov 67 www.quintiles.com 67 www.aveopharma.com 67 www.rxipharma.com 67 Inc. NASDAQ MBLX 67 please visit http:/www.elan.com 66 www.nextgen.com 66 please visit www.abraxisbio.com 66 Attracting Bullish Investors 66 please visit www.broadridge.com 66 education visit www.mayo.edu 66 Regulatory Disclosure 66 please visit www.irobot.com 66 www.vical.com 66 Provides Shareholder 65 report visit http:/www.aberdeen.com/link/sponsor.Rodrigo Santoro 65 www.delcath.com 65 www.polymedix.com 65 www.bd.com 65 By Neil Osterweil 65 site www.ambrilia.com 65 leading lipid nanoparticle 65 developing Zerenex TM 65 Report companiesandmarkets.com adds 65 Jumps Higher 65 Enrolls First 65 FREE Whitepaper 65 Guides Inline 65 ® bortezomib 65 NASDAQ CRXL 65 Q2 Loss Narrows 65 Exploit collaboration 64 Announces Additions 64 Q3 Loss Narrows 64 Announces Organizational Changes 64 Completes Enrollment 64 Q1 Loss Narrows 64 www.implantsciences.com 64 Signs License Agreement 64 Strengthens Leadership 64 Nasdaq VTIV 64 Amphion Innovations plc 64 Inc. NASDAQ RRGB 64 Antigen Express website 64 www.axiscapital.com 64 www.akorn.com 64 Owlstone Nanotech Inc. 64 Q2 Loss Widens 64 YOUR LOCAL ANIMAL SHELTER 64 www.transcept.com 64 ABAXIS 64 Joins OTCQX 64 AACR publishes five 64 By MATT KATZ 64 pharma.com 63 Webcast Presentations 63 Crucell NV NYSE Euronext 63 Joseph Levi Esq 63 Small Molecule 63 Post Earnings Checkup 63 By PETER LARSEN 63 please visit http:/www.gene.com 63 FDA Clears 63 Reports Profitable 63 Announces Adjournment 63 Shareholders Approve Acquisition 63 Inc. Nasdaq CYBX 63 Deloitte commends 63 Completes Tender Offer 63 MorphoSys AG FSE MOR 63 optical biosensors 63 Explore Strategic Alternatives 63 MultiCell Technologies 63 http:/www.biolase.com 63 molecular imaging radiotherapeutics 63 By RICK CASEY